ADVANCED GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for ADVANCED GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug cocktail aims to tackle Hard-to-Treat stomach cancer

Disease control Not yet recruiting

This study tests a new biologic drug called HCB101 in combination with other cancer drugs (zolbetuximab and chemotherapy) for people with advanced gastric or gastro-esophageal cancer. The goal is to find a safe dose and see if the combination can shrink tumors. About 40 adults wi…

Matched conditions: ADVANCED GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Disease control

Last updated Jul 03, 2026 20:00 UTC

ADVANCED GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new ADVANCED GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New drug cocktail aims to tackle Hard-to-Treat stomach cancer